LINE-1 Methylation as a Prognostic Factor in Gliomas
Author Information
Author(s): Ohka Fumiharu, Natsume Atsushi, Motomura Kazuya, Kishida Yugo, Kondo Yutaka, Abe Tatsuya, Nakasu Yoko, Namba Hiroki, Wakai Kenji, Fukui Takashi, Momota Hiroyuki, Iwami Kenichiro, Kinjo Sayano, Ito Maki, Fujii Masazumi, Wakabayashi Toshihiko
Primary Institution: Nagoya University School of Medicine
Hypothesis
MGMT promoter methylation might reflect global DNA methylation.
Conclusion
Higher LINE-1 methylation is a favorable prognostic factor in primary GBMs.
Supporting Evidence
- IDH1/2 mutation is closely correlated with MGMT promoter methylation in LGGs.
- LINE-1 methylation levels in primary and secondary GBMs are lower than those in LGGs and normal brain tissues.
- Higher LINE-1 methylation is a favorable prognostic factor in primary GBMs.
Takeaway
This study found that a specific type of DNA methylation, called LINE-1 methylation, can help predict how well patients with brain tumors called gliomas will do.
Methodology
The study analyzed DNA from tumor samples using pyrosequencing and multiplex ligation-dependent probe amplification to assess methylation levels and genetic alterations.
Limitations
The study had a limited number of secondary GBM samples and did not fully explore the mechanisms behind the observed correlations.
Participant Demographics
{"age":{"median":42,"range":"21-84"},"sex":{"male":63,"female":37}}
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 17.1–74.3 months for PFS; 95% CI: 8.9–336.8 months for OS
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website